Airway Management Devices is growing at 10.28% a year, the fastest of any product type in the disposable resuscitation devices market, and it is gaining ground on the bag valve mask lines that have long anchored hospital and ambulance stock. Its share of revenue climbs from 11.6% to 16.1% over the forecast period, while its value moves from USD 0.15 billion to USD 0.35 billion.
Contrive Datum Insights has published "Disposable Resuscitation Devices Market Size, Share & Industry Analysis, By Product type, Type, Application, End user, Distribution channel, and Regional Forecast, 2026-2034." The study sizes the global market at USD 1.29 billion in 2025, with USD 1.37 billion expected in 2026 and USD 2.18 billion by 2034, a compound annual growth rate of 5.98%.
Why Airway Management Is Pulling Ahead
Disposable resuscitation devices are single-use airway and ventilation products used to support breathing during cardiac arrest, surgery, trauma or respiratory failure. Because each unit is discarded after one patient, buyers avoid the cross-contamination risk of cleaned and reused equipment.
The study names rising EMS infrastructure investment and ambulance fleet expansion as the largest single contributor to growth, and rates its impact high. Airway management products sit closest to that spending, which explains why the line outpaces a market growing at 5.98%. The end-user data points the same way: Emergency Medical Services (EMS) & Pre-hospital is the fastest-growing end user at 7.41%, even though Hospitals lead in 2025 with 55% of revenue at USD 0.71 billion.
Scenario analysis brackets the outlook. A bull case, built on faster single-use conversion in Asia Pacific and Latin America and quicker EMS fleet growth in emerging markets, lifts 2034 revenue to USD 2.47 billion. A bear case, with slower conversion in cost-constrained public health systems and weaker hospital capital spending in key developed markets, holds it to USD 1.92 billion.
Geography shows where that demand is concentrated. North America is the largest region, with 34% of 2025 revenue at USD 0.44 billion, reaching USD 0.68 billion by 2034. Asia Pacific is the region gaining share, rising from 24% to 29% as revenue grows from USD 0.31 billion to USD 0.63 billion. Middle East and Africa stays the smallest at 7% in both 2025 and 2034. The United States is the largest single country market, at USD 0.37 billion in 2025 and 28.7% of global revenue.
Other segments add their own pockets of speed. Online & Retail Pharmacies grows fastest among distribution channels at 9.87%, though Direct/Institutional Tenders still lead with 48% of revenue. Kid devices grow at 7.12%, well ahead of Adult, which holds 78% of revenue. In application terms, Hospital leads with 71% and Clinic grows fastest at 7%.
The Largest Line Moves More Slowly
Manual Resuscitators (Bag Valve Mask) remains the biggest product type, with 41.9% of 2025 revenue at USD 0.54 billion. Its growth of 5.65% trails the overall market's 5.98%, and its share edges down to 41.3% by 2034. Scale protects it, but it does not give it momentum. Any supplier counting on the volume of the established line alone will watch the faster segment close in.
The report covers five axes: product type, type, application, end user and distribution channel. It provides revenue and growth rates for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios, all five regions with country-level breakdowns, the competitive landscape and the research methodology behind each estimate. It is delivered as a PDF, and a free sample is available on request.